Simon Chell

Vice President of Biologics Engineering @AstraZeneca

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2022 — Present

Vice President of Biologics Engineering @AstraZeneca

View department →

I lead the discovery of AstraZeneca\'s biological therapeutics - including antibodies, multi-specifics, antibody-drug conjugates, antibody fragments, peptides and cell therapies. This includes exploring novel disease biology, developing novel drug formats and delivering technological innovations through multidisciplinary international departments including antibody discovery, protein & cell engineering, assay sciences and cell therapy.

EDUCATION

2001 — 2005

University of Bristol

Doctor of Philosophy - PhD, Cell and Molecular Medicine

2000 — 2001

University of Kent

Master's degree, Oncology and Cancer Biology

1996 — 1999

University of Kent

Bachelor of Science - BS, Biochemistry

SKILLS

BiotechnologyGlobal HealthDrug DevelopmentBiopharmaceuticalsGlobal Cross-Functional Team LeadershipBiologyCollaborative LeadershipMolecular OncologyPharmaceutical IndustryLife SciencesDrug DiscoveryClinical ResearchCancer ResearchMolecular Biology

ABOUT SIMON CHELL

I am a leader in drug discovery, with a background in large and small molecule medicine…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Simon Chell — Vice President of Biologics Engineering at AstraZeneca in Cambridge, GB | Unifers